Status: Recruiting
PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
This is a Phase I Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics and Preliminary Antitumor Activity of PE0116 and PE0105 Injection in Treatment of Patients with Advanced Solid Tumor.
Participants needed: 120
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai HyaMab Biotech Co.,Ltd.Updated: Dec 15, 2023Locations: 1
Eligibility criteria
Patients who voluntarily sign the informed consent form, understand the study an... [+19]
Subjects who have central nervous system metastasis with clinical symptoms (e.g.... [+21]